Diagnostics of Scaphoid Fractures With HRpQCT
Launched by VIECURI MEDICAL CENTRE · Mar 29, 2019
Trial Information
Current as of April 29, 2025
Unknown status
Keywords
ClinConnect Summary
Scaphoid fractures
The scaphoid bone is the most frequently occurring fracture of the carpal bones. Scaphoid fractures represent 2-6% of all fractures and 90% of all carpal fractures in the Netherlands. Scaphoid fractures typically occur in young, active patients aged 15 to 40 years old. The exact incidence is unknown, but approximately 21,000 scaphoid fractures are suspected in the Netherlands each year. However, only 15 to 30% represent real fractures. Because a significant amount of fractures (up to 65% immediately after injury) remain radiographically occult with conventional radiograp...
Gender
ALL
Eligibility criteria
- • Phase I - Diagnostic phase
- • Inclusion criteria
- In order to be eligible to participate in Phase I of the study, a subject must meet all of the following criteria:
- • 1. Adults (18 years or older) who visit the emergency department of the VieCuri Medical Center Venlo with a clinically suspected scaphoid fracture due to a trauma (\<1 week after trauma).
- • 2. Patients who understand the conditions of the study and are willing and able to comply with the scheduled radiographic evaluations and the prescribed treatment and rehabilitation.
- • 3. Patients who signed the Ethics Committee approved specific informed consent form prior to inclusion.
- • Exclusion criteria
- A potential subject who meets the following criterion will be excluded from participation in this study:
- • 1. Patients, who as judged by the principal investigator, are mentally compromised or are unlikely to be compliant with the follow-up evaluations schedule.
- • 2. Patients with a scaphoid fracture at the ipsilateral side in medical history
- • 3. Pregnancy.
- • Phase II - Follow-up phase
- • Inclusion criteria
- In order to be eligible to participate in Phase II of the study, a subject must meet all of the following criteria:
- • 1. Patients who completed Phase I of the study and have a radiographically confirmed scaphoid fracture on CT or HR-pQCT.
- • 2. Patients who signed the Ethics Committee approved specific informed consent form prior to inclusion.
- • 3. Conservatively treated scaphoid fractures.
- • Exclusion criteria
- A potential subject who meets the following criterion will be excluded from participation in this study:
- • 1. Patients, who as judged by the principal investigator, are mentally compromised or are unlikely to be compliant with the follow-up evaluations schedule.
- • 2. Pregnancy
About Viecuri Medical Centre
Viecuri Medical Centre is a leading healthcare institution dedicated to advancing medical knowledge and patient care through innovative clinical research. Located in the Netherlands, Viecuri is committed to conducting high-quality clinical trials that adhere to the highest ethical and regulatory standards. The center employs a multidisciplinary approach, leveraging a team of experienced healthcare professionals and researchers to develop and implement studies across various therapeutic areas. With a focus on enhancing treatment options and improving patient outcomes, Viecuri Medical Centre plays a pivotal role in translating scientific research into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Venlo, Limburg, Netherlands
Patients applied
Trial Officials
Heinrich Janzing, MD, PhD
Principal Investigator
VieCuri MC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials